Third quarter revenues up 6% driven by EXPAREL volume growth of 9% -- -- Several key milestones advance 5x30 path to growth ...
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia Key takeaways: IAVI's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback